PMV Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Pmv Pharmaceuticals

12/11/2021 14:30

* PMV Pharmaceuticals Inc  PMVP.OQ  reported a quarterly
adjusted loss of 33 cents​​ per share for the quarter ended in
September. The mean expectation of six analysts for the quarter
was for a loss of 30 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* PMV Pharmaceuticals Inc's reported EPS for the quarter was a
loss of 33 cents​.
* The mean earnings estimate of analysts had risen by about 0.1%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* PMV Pharmaceuticals Inc shares had fallen by 20.5% this
quarter and lost 61.5% so far this year.
* The company reported a quarterly loss of $15.01 million.
* Wall Street's median 12-month price target for PMV
Pharmaceuticals Inc is $63.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 12 at 02:30 p.m.
 ​All figures in US dollars unless otherwise stated